Similar articles

• Dose-dependent relationship between SGLT2 inhibitor hold time and risk for postoperative anion gap acidosis: a single-centre retrospective analysis.

  Steinhorn B, Wiener-Kronish J. Steinhorn B, et al. Br J Anaesth. 2023 Oct;131(4):682-686. doi: 10.1016/j.bja.2023.06.063. Epub 2023 Aug 2. Br J Anaesth. 2023. PMID: 37541949
• Risk of perioperative discontinuation of SGLT2 inhibitors.

  Oosterom-Eijmael MJP, Hermanides J, van Raalte DH, Hulst AH. Oosterom-Eijmael MJP, et al. Br J Anaesth. 2024 Aug;133(2):239-240. doi: 10.1016/j.bja.2024.05.004. Epub 2024 Jun 4. Br J Anaesth. 2024. PMID: 38834489
• Perioperative use of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors for diabetes mellitus.

  Dhatariya K, Levy N, Russon K, Patel A, Frank C, Mustafa O, Newland-Jones P, Rayman G, Tinsley S, Dhesi J. Dhatariya K, et al. Br J Anaesth. 2024 Apr;132(4):639-643. doi: 10.1016/j.bja.2023.12.015. Epub 2024 Jan 29. Br J Anaesth. 2024. PMID: 38290906
• Diuretics, SGLT2 inhibitors and falls in older heart failure patients: to prescribe or to deprescribe? A clinical review.

  van Poelgeest EP, Handoko ML, Muller M, van der Velde N; EUGMS Task & Finish group on Fall-risk-increasing drugs. van Poelgeest EP, et al. Eur Geriatr Med. 2023 Aug;14(4):659-674. doi: 10.1007/s41999-023-00752-7. Epub 2023 Feb 3. Eur Geriatr Med. 2023. PMID: 36732414 Free PMC article. Review.
• Euglycemic Diabetic Ketoacidosis Associated With Sodium-Glucose Cotransporter-2 Inhibitors After Cardiac Surgery: A Review of Current Literature.

  Branco A, Fatima R, Liblik K, Jackson R, Payne D, El-Diasty M. Branco A, et al. J Cardiothorac Vasc Anesth. 2022 Oct;36(10):3877-3886. doi: 10.1053/j.jvca.2022.06.008. Epub 2022 Jun 16. J Cardiothorac Vasc Anesth. 2022. PMID: 35863986 Review.